Current assets decreased 24.8%
Current assets changed -24.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$281.4M→$211.5M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →SPRY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Research & development increased 16.4%
Research & development changed +16.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$4.0M→$4.7M3 prior comparisons
Receivables / revenue moved 2070 bp lower
Receivables / revenue changed -2070 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
159.87%→139.16%2 prior comparisons
Total assets decreased 20.4%
Total assets changed -20.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$313.5M→$249.5M4 prior comparisons
SBC / revenue moved 265 bp higher
SBC / revenue changed +265 basis points from the comparable as-filed period.
34.17%→36.83%3 prior comparisons
Capital expenditure decreased 100.0%
Capital expenditure changed -100.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$51,000→$04 prior comparisons
Current ratio decreased 43.7%
Current ratio changed -43.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
6.17→3.484 prior comparisons
R&D / revenue moved 1171 bp lower
R&D / revenue changed -1171 basis points from the comparable as-filed period.
25.67%→13.96%3 prior comparisons
Free-cash-flow margin moved 7121 bp higher
Free-cash-flow margin changed +7121 basis points from the comparable as-filed period.
-252.23%→-181.02%3 prior comparisons
Operating cash-flow margin moved 7089 bp higher
Operating cash-flow margin changed +7089 basis points from the comparable as-filed period.
-251.91%→-181.02%3 prior comparisons
Capex / revenue moved 32 bp lower
Capex / revenue changed -32 basis points from the comparable as-filed period.
0.32%→0.00%3 prior comparisons
Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 7 prior comparable changes.
98,826,337→99,447,3437 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.